Edition:
United States

Soligenix Inc (SNGX.OB)

SNGX.OB on OTC BB

0.78USD
2:42pm EDT
Change (% chg)

$-0.05 (-5.91%)
Prev Close
$0.83
Open
$0.80
Day's High
$0.84
Day's Low
$0.78
Volume
33,864
Avg. Vol
87,252
52-wk High
$1.44
52-wk Low
$0.44

SNGX.OB

Chart for SNGX.OB

About

Soligenix, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical... (more)

Overall

Beta: 1.98
Market Cap(Mil.): $27.84
Shares Outstanding(Mil.): 33.58
Dividend: --
Yield (%): --

Financials

  SNGX.OB Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -0.02 -- --
ROI: -- -0.26 13.91
ROE: -- -3.05 14.82

BRIEF-Soligenix Q2 EPS $0.00

* Soligenix announces recent accomplishments and second quarter 2016 financial results highlighted by revenues of $3.2 million

Aug 11 2016

BRIEF-Soligenix appoints Karen Krumeich as CFO

* Soligenix appoints Karen Krumeich, as chief financial officer Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 20 2016

BRIEF-Soligenix announces presentation of phase 2 oral mucositis clinical trial results

* Soligenix announces presentation of phase 2 oral mucositis clinical trial results at the 2016 multinational association for supportive care in cancer conference Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 06 2016

BRIEF-FDA grants Soligenix "fast track" designation for SGX943

* FDA grants Soligenix "fast track" designation for SGX943 for the treatment of melioidosis Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 31 2016

BRIEF-Soligenix Q1 loss per share $0.04

* Soligenix announces recent accomplishments and first quarter 2016 financial results

May 12 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Streetwise Reports
$12.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.